Jeremy M. Levin

Insider Reports History

Signature
/s/ Jason Minio, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Jeremy M. Levin:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Ovid Therapeutics Inc. CEO, Director Common Stock 3.62M $9.98M $2.76 18 Mar 2024 Direct
Ovid Therapeutics Inc. CEO, Director Common Stock 35.5K $97.9K $2.76 18 Mar 2024 Indirect
Ovid Therapeutics Inc. CEO, Director Employee Stock Option (Right to Buy) 1.65M 20 Feb 2025 Direct
Ovid Therapeutics Inc. CEO, Director Stock Option (Right to Buy) 700K 22 Feb 2024 Direct

Insider Reports Filed by Jeremy M. Levin

Symbol Company Period Transactions Value $ Form Type Role Filing Time
OVID Ovid Therapeutics Inc. 20 Feb 2025 1 $0 4 CEO, Director 24 Feb 2025, 19:55
OVID Ovid Therapeutics Inc. 18 Mar 2024 1 $50.4K 4 CEO, Director 20 Mar 2024, 17:22
OVID Ovid Therapeutics Inc. 22 Feb 2024 1 $0 4 CEO, Director 26 Feb 2024, 17:58
OVID Ovid Therapeutics Inc. 04 Dec 2023 2 $0 4 CEO, Director 06 Dec 2023, 17:05
OVID Ovid Therapeutics Inc. 23 Feb 2023 1 $0 4 CEO, Director, 10%+ Owner 27 Feb 2023, 15:58
OVID Ovid Therapeutics Inc. 08 Apr 2022 1 $0 4 CEO, Director, 10%+ Owner 12 Apr 2022, 17:36
OVID Ovid Therapeutics Inc. 03 Feb 2022 1 $0 4 CEO, Director, 10%+ Owner 04 Feb 2022, 17:14
OVID Ovid Therapeutics Inc. 08 Oct 2019 1 $0 4/A CEO, Director 14 Feb 2024, 16:15